Status:
UNKNOWN
Study of Complex Intracranial Aneurysm Treatment
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation
Conditions:
Intracranial Aneurysm
Eligibility:
All Genders
Up to 75 years
Phase:
NA
Brief Summary
The investigator expects that endovascular flow-diversion is superior over revascularization by postoperative modified Rankin scale (mRS) in patients with complex intracranial aneurysms.
Detailed Description
Open, prospective, controlled randomized superiority trial is conducted. The hypothesis is that endovascular flow-diversion is better than revascularization in treatment of complex intracranial aneury...
Eligibility Criteria
Inclusion
- anterior circulation complex intracranial aneurysm
- neck is more than 4 mm wide
- dome/neck ratio of aneurysm equals or less than 2:1
- age less than 75 years
- ability to give informed consent (subject or legally authorized representative)
- aneurysm is suitable for treatment to both procedures
Exclusion
- subarachnoid hemorrhage less than 30 days ago
- contraindications to endovascular treatment
- atypical aneurysms (mycotic, flow-related in patients with AVM, traumatic, false)
- informed consent refusal
Key Trial Info
Start Date :
March 14 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03269942
Start Date
March 14 2015
End Date
June 1 2018
Last Update
September 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novosibirsk Research Institution of Circulation Pathology
Novosibirsk, Russia, 630055